您的购物车当前为空
别名 PPI-5278, PBI-200
Paltimatrectinib (PBI-200) 是一种高效的酪氨酸激酶 (tyrosine kinase) 抑制剂,具有抗癌活性,抑制肌球蛋白相关激酶 A (TrkA) 。Paltimatrectinib 可用于研究膀胱癌、乳腺癌和结直肠癌。

Paltimatrectinib (PBI-200) 是一种高效的酪氨酸激酶 (tyrosine kinase) 抑制剂,具有抗癌活性,抑制肌球蛋白相关激酶 A (TrkA) 。Paltimatrectinib 可用于研究膀胱癌、乳腺癌和结直肠癌。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 1,290 | In Stock |
Paltimatrectinib 相关产品
| 产品描述 | Paltimatrectinib (PBI-200) is a potent tyrosine kinase inhibitor with anticancer activity that inhibits myosin-related kinase A (TrkA).Paltimatrectinib is used in the study of bladder, breast and colorectal cancers. |
| 别名 | PPI-5278, PBI-200 |
| 分子量 | 434.37 |
| 分子式 | C20H15F5N6 |
| CAS No. | 2353522-15-1 |
| Smiles | [H][C@@]1(CCCN1c1ccn2ncc(-n3cc(cn3)C(F)(F)F)c2n1)c1cc(F)ccc1F |
| 颜色 | Yellow |
| 物理性状 | Solid |
| 存储 | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||
| 溶解度信息 | DMSO: 10 mg/mL (23.02 mM), Sonication is recommended. | |||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||
评论内容